Literature DB >> 6318289

Antimicrobial resistance in hospital organisms and its relation to antibiotic use.

J E McGowan.   

Abstract

Organisms causing nosocomial infection are frequently resistant to antimicrobial agents. Studies of the reasons for this have been hindered by difficulties in defining terms, by selection biases, by artifacts produced by study methods, and by failure to control for confounding variables. Major factors leading to increased prevalence of resistant organisms in hospitals are changes in organisms causing nosocomial infection (due in part to changes in characteristics of hospital populations and in procedures and instruments used in patient care), increasing prevalence of resistance in bacteria causing community-acquired infection, and use of antimicrobial agents. A causal relationship between antibiotic usage and resistance of hospital organisms is supported by consistent association and concurrent variation in several populations, presence of a dose-response pattern, and existence of a reasonable biologic model to explain the relationship. Major influences on emergence of resistant hospital bacteria include antimicrobial effects in treated individuals, mechanisms for transfer of resistance between bacteria, and routes of transmission within the hospital for bacteria or their resistance factors. Barrier isolation techniques can help control resistant hospital bacteria. However, virtually all reports agree that careful, discriminating use of antimicrobial agents remains the keystone for minimizing this problem. This need must be communicated more effectively to prescribers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318289     DOI: 10.1093/clinids/5.6.1033

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  114 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

Authors:  M Lipsitch; C T Bergstrom; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

3.  Role of Antimicrobial Stewardship in Prevention and Control of Antibiotic Resistance.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

4.  Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.

Authors:  M Bertin; A Muller; X Bertrand; C Cornette; M Thouverez; D Talon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

5.  Structured representation of the pharmacodynamics section of the summary of product characteristics for antibiotics: application for automated extraction and visualization of their antimicrobial activity spectra.

Authors:  Catherine Duclos; Gian Luigi Cartolano; Michael Ghez; Alain Venot
Journal:  J Am Med Inform Assoc       Date:  2004-04-02       Impact factor: 4.497

6.  Antimicrobial stewardship.

Authors:  Shira Doron; Lisa E Davidson
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

7.  Antimicrobial resistance: The never ending story.

Authors:  L E Nicolle
Journal:  Can J Infect Dis       Date:  1991

8.  A multidisciplinary hospital-based antimicrobial use program: Impact on hospital pharmacy expenditures and drug use.

Authors:  S Salama; C Rotstein; L Mandell
Journal:  Can J Infect Dis       Date:  1996-03

9.  Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies.

Authors:  Y X Liew; W Lee; Y Y Cai; J Teo; S S-L Tang; R W-Q Ong; C L-L Lim; P B Lingegowda; A L-H Kwa; M P Chlebicki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-08       Impact factor: 3.267

10.  High frequency of antimicrobial resistance in human fecal flora.

Authors:  S B Levy; B Marshall; S Schluederberg; D Rowse; J Davis
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.